Hem › Burkitts lymfom › Washington › Spokane

Kliniska studier för Burkitts lymfom i Spokane, WA

4 studier för Burkitts lymfom söker deltagare vid platser i och runt Spokane (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

RekryterarFas 2

Providence Sacred Heart Medical Center and Children's Hospital, Spokane

366 Days – 46 Years · Alla kön · Uppdaterad 2 okt. 2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

RekryterarFas 2

Providence Sacred Heart Medical Center and Children's Hospital, Spokane

365 Days · Alla kön · Uppdaterad 25 sep. 2026 · NCT06317662

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

RekryterarFas 2

Providence Sacred Heart Medical Center and Children's Hospital, Spokane

Ålder 1 till 30 · Alla kön · Uppdaterad 1 sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RekryterarFas 3

Providence Sacred Heart Medical Center and Children's Hospital, Spokane

365 Days – 25 Years · Alla kön · Uppdaterad 25 aug. 2026 · NCT03959085

Burkitts lymfom-studier i andra städer

Andra studier i Spokane

Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.